Difference between revisions of "Team:NCTU Formosa/Design"
Line 183: | Line 183: | ||
</p> | </p> | ||
<div class="image"> | <div class="image"> | ||
− | <img src="https://static.igem.org/mediawiki/2015/ | + | <img src="https://static.igem.org/mediawiki/2015/e/ef/Nctu_Formosa_design_newfig2.png" height="300px"> <br><br> |
Figure 2. We design the platform to detect multimarkers as the reference for applying the combination therapy. | Figure 2. We design the platform to detect multimarkers as the reference for applying the combination therapy. | ||
</div> | </div> |
Revision as of 19:14, 18 September 2015
Core of APOllO E.Cotector: Customization
By utilizing the concept of cotransformation, APOllO can offer various E.Cotectors with scFv, color signal or GBP and even any desired combination. Therefore, APOllO could customize the E.Cotector to satisfy the need of various detection platforms.
![](https://static.igem.org/mediawiki/2015/0/07/Nctu_formosa_design_newfig1.png)
Figure 1. With the co-transform technique, we can insert any scFv or signal-related genetic sequences into the E.coli, and create a customized platform ─ the APOllO E.Cotector.
Single Chain Variable Fragment
Probe: scFv from targeted drug
In order to provide doctors with new, direct, and innovative methods in determining the usage of monoclonal-antibody-targeted drugs, we redesigned the FDA approved monoclonal antibody targeted drugs, such as Bevacizumab (Avastin® anti-VEGF) [1], Cetuximab (Erbitux® anti-EGFR) [2] and Trastuzumab (Herceptin® anti-HER2) [3] into scFv as probes.
![](https://static.igem.org/mediawiki/2015/e/ef/Nctu_Formosa_design_newfig2.png)
Figure 2. We design the platform to detect multimarkers as the reference for applying the combination therapy.
Each distinct scFv of targeted drug is displayed on the surfaces of E.coli. ScFv from targeted drugs can specifically detect target molecules.
Furthermore, as APOllO E.Cotector expressed scFv and color signal at the same time, the specific molecules that correspond to those scFv can be identified by different colors, hence offering an accurate prescription of monoclonal antibody targeted drug.
![](https://static.igem.org/mediawiki/2015/thumb/a/a6/Figure_2_E.Cotector.png/800px-Figure_2_E.Cotector.png)
Figure 3. E.Cotector
Transmembrane Protein of scFv
To display scFv on the surface of E.coli, we use a transmembrane protein. The transmembrane protein is composed of lipoprotein (Lpp) and outer membrane protein A (OmpA).
![](https://static.igem.org/mediawiki/2015/3/30/Figure_3_Transmembrane_Protein_Lpp_OmpA.png)
Figure 4. Transmembrane protein: Lpp-OmpA is composed of lipoprotein (Lpp) and outer membrane protein A (OmpA).
Lpp-OmpA was designed as a fusion protein consisting of the signal sequence and first 9 amino acids of Lpp, residue 46~159 amino acids of OmpA. The Lpp of the N-terminal of this fusion protein targets the protein on the membrane while the transmembrane domain of OmpA serves as an anchor. ScFv is on the externally exposed loops of C-terminal of OmpA, which can be anchored to the outer membrane. Between the OmpA and scFv, there is a cut site of restriction enzyme called NcoI. With this cut site, the linked scFv can be easily changed like a cassette [1].
![](https://static.igem.org/mediawiki/2015/b/b4/Figure_4_NocI_scFv.png)
![](https://static.igem.org/mediawiki/2015/8/84/Nctu_formosa_design_figure4-2.png)
![](https://static.igem.org/mediawiki/2015/b/b4/Lpp-OmpA_NcoI.png)
![](https://static.igem.org/mediawiki/2015/a/ab/Ncol_scFv.png)
Figure 5. To change the scFv sequence easily, we designed the NcoI restriction site between Lpp-Omp A and scFv. When designing XbaI-SpeI restriction site between Lpp-OmpA and scFv, it cause mixed site. Therefore, NcoI restriction site rather than EX-SP restriction site was designed.
Color Signal
The color signals that we have selected are flourescence proteins and chromoproteins. Cooperating with iGEM, all of resources were from the giant registry of iGEM which is accessible to every iGEMer. APOllO utilized the red flourescent protein BBa_E1010, the green fluorescent protein BBa_E0040, the blue fluorescent protein BBa_K592100, and the blue chromoprotein BBa_K592009.
![](https://static.igem.org/mediawiki/2015/4/48/Design_Figure_5-1.png)
![](https://static.igem.org/mediawiki/2015/2/26/Design_Figure_5.png)
![](https://static.igem.org/mediawiki/2015/d/d3/Design_Figure_5-3.png)
Figure 6. Different Color Signal
Gold Binding Polypeptide
Another plasmid is gold binding polypeptide, abbreviated as GBP. APOllO may display GBP on the surface of E.coli for binding on gold surface.
GBP was designed with the three-repeated following 14 amino acid sequences: [MHGKTQATSGTIQS]. The binding sequence of GBP does not contain cysteine which can form a covalent thiol linkage with gold, the linkage to the gold surface in Self-Assembled Monolayers (SAMs)[2].
The mechanism of the connection between GBP and gold metal plane remains unknown. By using Molecular Dynamics (MD), it indicates that GBP, with an antiparallel β-sheet structure, can recognize gold surface via OH-binding. It is likely that the hydroxyl, together with amine, ligands on GBP recognize the atomic lattice of gold, aligning the molecule along the variants of a six-fold axis on the Au (111) surface [3].
![](https://static.igem.org/mediawiki/2015/thumb/3/36/Design_Figure_6.png/800px-Design_Figure_6.png)
Figure 7. GBP can recognize and bind on the gold surface.
Transmembrane Protein of GBP
To display the GBP to the outer membrane of E.Cotector, we use a transmembrane protein called Long-chain fatty acid short as FadL. We selected the first 384 amino acid sequence from the FadL for the transmembrane protein of GBP.
![](https://static.igem.org/mediawiki/2015/thumb/1/1a/Design_Figure_7.png/800px-Design_Figure_7.png)
Figure 8. Transmembrane Protein FadL transports GBP out of the surface of E.coli
Application: Immobilize on Gold
Via concept of biosensor, APOllO’s customers may deem the E.Cotector to play the role of biological recognition part and the gold chip to act as the signal transducer part. Combining with multiple physicochemical nanoscale detectors in various fields, such as optical, electrochemistry, microbalance and etcetera, greater precision and accuracy will be achieved.
![](https://static.igem.org/mediawiki/2015/7/79/Nctu_formosa_design_figure12.png)
Figure 9. Concept of Biosensor via E.Cotector
[1] UniProtKB - P0A910 (OMPA_ECOLI)
[2] Adsorption of genetically engineered proteins studied by time-of-flight secondary ion mass spectrometry (TOF-SIMS). Part A: data acquisition and principal component analysis (PCA), Noriaki Suzuki,1 Lara Gamble,2 Candan Tamerler,3 Mehmet Sarikaya,1 David G. Castner2,4 (2007)
[3] Assembly of Gold-Binding Proteins for Biomolecular Recognition, Zareie HM1,2* and Sarikaya M3, Austin Journal of Biosensors & Bioelectronics (2015)